- Previous Rank8
- Revenue 3 Yr Annual Growth Rate36%
- Revenue 3 Yr Growth Rank37
- EPS 3 Yr Annual Growth Rate88%
- EPS 3 Yr Growth Rank11
- Total Return 3 Yr Annual Rate79%
- Total Return 3 Yr Rank4
Maker of the first artificial heart, Abiomed’s revenues have been racing on sales of the Impella heart pump for patients with heart failure, a growing market.
Company Information
Revenue and net income for the four quarters ended on or before April 30, 2017. Total return for the period ended June 30, 2017.
| Location | Danvers, Mass. |
| Industry | Medical Products & Equipment |
| Sector | Health Care |
| Current Streak | 3 |
| Years on List | 3 |
| CEO | Michael Minogue |
| Website | http://www.abiomed.com |
Revenue, Net Income
| Revenue past four quarters ($M) | $445 |
| Net Income past four quarters ($M) | $52 |
Growth Rates and Ranks
| Revenue 3 Yr Growth Rank | 37 |
| Revenue 3 Yr Annual Growth Rate | 36% |
| EPS 3 Yr Growth Rank | 11 |
| EPS 3 Yr Annual Growth Rate | 88% |
| Total Return 3 Yr Rank | 4 |
| Total Return 3 Yr Annual Rate | 79% |
| Beat S&P 500 (9.6%) | yes |
| P/E Ratio | 66 |